March 29, 2022
Accenture Joins AI4BetterHearts Information Collaborative
International collaborative targets to enhance cardiovascular well being
NEW YORK; March 29, 2022 – Accenture (NYSE: ACN) has joined AI4BetterHearts, an international records collaborative based via Microsoft and the Novartis Basis, that targets to assist stakeholders —
from coverage makers to sufferers — make higher selections about middle well being and enhance the well being of whole populations.
Heart problems (CVD) is the main explanation for dying globally. 3-quarters of CV deaths happen in low- and middle-income international locations, and plenty of are preventable.
AI4BetterHearts leverages middle well being records from other resources, the usage of synthetic intelligence (AI) and complicated analytics to raised perceive the drivers of CV well being, together with well being inequities, in massive populations. Accenture joins the collaboration to additional the advance of AI insights that may assist enhance population-wide cardiovascular well being results.
“We’re becoming a member of the AI4BetterHearts collaborative to assist additional its ambitions to stop heart problems. Via making use of era, we will be able to increase data-driven insights on the real catalysts of well being and fairness and assist pressure knowledgeable selections for coverage trade,” stated Stuart Henderson, international Existence Sciences lead for Accenture. “We purpose to give a contribution to sustainable inhabitants well being via integrating innovation and rising applied sciences.”
Ann Aerts, head of the Novartis Basis, stated, “We’re growing new open-source AI insights that may assist coverage makers, well being execs and sufferers make higher selections about well being and in the long run enhance the center well being of whole populations. We look ahead to welcoming new companions who percentage our project and who need to leverage their records and experience for inhabitants well being have an effect on.”
Accenture’s Existence Sciences trade crew is helping pharmaceutical, biotech, scientific era, distributor and shopper well being corporations mix the most recent era with clinical breakthroughs to revolutionize how scientific therapies are came upon, evolved and dropped at sufferers all over the world. To be informed extra, discuss with https://www.accenture.com/us-en/industries/life-sciences-index.
About Accenture
Accenture is an international skilled products and services corporate with main features in virtual, cloud and safety. Combining unrivaled enjoy and specialised abilities throughout greater than 40 industries, we provide Technique and Consulting, Interactive, Era and Operations products and services — all powered via the sector’s greatest community of Complicated Era and Clever Operations facilities. Our 699,000 folks ship at the promise of era and human ingenuity on a daily basis, serving shoppers in additional than 120 international locations. We embody the facility of trade to create price and shared luck for our shoppers, folks, shareholders, companions and communities. Consult with us at accenture.com.
# # #
Touch:
Marchell Gillis
Accenture
+1 678 657 7515 (administrative center)
+1 404 409 9430 (cellular)
marchell.gillis@accenture.com
Copyright ©2022 Accenture. All rights reserved. Accenture and its emblem are registered logos of Accenture.
This content material is supplied for basic data functions and isn’t meant for use instead of session with our skilled advisors. This report refers to marks owned via 1/3 events. All such third-party marks are the valuables in their respective house owners. No sponsorship, endorsement or approval of this content material via the house owners of such marks is meant, expressed or implied.
